Background: Haemophilia is a genetic bleeding disorder that often results in joint damage and muscle weakness due to recurrent hemarthrosis, which significantly affects gait. Physiotherapy interventions such as resistance training may help improve muscle strength and restore functional gait parameters in affected individuals. Objective: To evaluate the impact of a TheraBand-based progressive resistance strength training program on gait characteristics—specifically step length, stride length, and toe-out angle—in individuals with haemophilia. Methods: A randomized controlled trial was conducted at the Haemophilia Day Care Centre, PGIMS Rohtak. A total of 69 male patients with moderate to severe haemophilia A were initially enrolled. Of these, 5 participants were excluded for not meeting the inclusion criteria, and 4 withdrew due to bleeding episodes during the study. Sixty participants were randomly assigned to either an intervention group (n=30), which received a 6-week TheraBand-based lower limb strength training program, or a control group (n=30), which continued with routine physiotherapy care. The primary outcome measures—step length, stride length, toe-out angle was assessed pre- and post-intervention using standardized footprint methods for gait analysis. Results: Post-intervention analysis revealed statistically significant improvements in the intervention group compared to the control group in step length (p < 0.01), stride length (p < 0.01), and toe-out angle (p < 0.05). No major adverse events were reported in the intervention group. Conclusion: TheraBand-based resistance training significantly enhances key gait parameters including step length, stride length, and toe-out angle in individuals with haemophilia. This intervention is safe and effective and should be considered as a valuable addition to physiotherapy protocols for this population.

This study presents a comprehensive analysis of the medicinal potential of Tridax procumbens, focusing on the physicochemical composition and antimicrobial activity of its aqueous, ethanolic, and petroleum ether extracts. Phytochemical screening revealed that all extracts contained multiple bioactive compounds, namely, alkaloids, glycosides, flavonoids, tannins, saponins, terpenoids, with the petroleum ether extract exhibiting the most consistent presence across plant parts. The effect of the extracts were tested on Escherichia coli, Enterobacter aerogenes Staphylococcus aureus, Klebsiella pneumonia, Pseudomonas aeruginosa, Salmonella spp and the yeast Candida albicans. Antimicrobial assays demonstrated notable zones of inhibition against the bacterial and fungal pathogens, with petroleum ether extracts of dried plant parts showing the highest efficacy. E. coli, S. aureus, and C. albicans were particularly susceptible. The findings highlight the potential of T. procumbens as a broad-spectrum antimicrobial agent and accentuate the importance of solvent type and plant part in determining phytochemical richness and therapeutic efficacy. This study provides more information on the constituents of different essential parts of the Tridax procumbens and confirms its use in the treatment of some ailments especially where the plant is ubiquitous.